CTRI/2024/02/063203尚未招募Unknown
Safety and efficacy of sacubitril/valsartan for systemic right ventricular dysfunction – a prospective observational study - Nil
Pediatric Cardiac Society of India0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •After obtaining written informed consent, all consecutive patients with systemic right ventricular dysfunction,
- •ie, systemic right ventricular ejection fraction (sRV EF) =40% or fractional area change (FAC) =35%, assessed
- •by ECHO would be included.
排除标准
- •1. Univentricular physiology
- •2. Systolic blood pressure < 90mmHg or <5th centile for age and height (whichever is lower)
- •3. GFR < 30ml/min/1.73m2
- •4. Serum potassium > 5.5 mEq/L
- •5. Previous intolerance to ACEi/ARB/ARNI
研究者
相似试验
尚未招募
1 期
Safety and efficacy of Sacubitril/Valsartan in blood pressure control of dialysis patientsCTRI/2020/02/023116Postgraduate Institute of Medical Education and Research
招募中
4 期
To assess the effectiveness and safety of adding sacubitril/valsartan to the standard treatment for the heart failure patientsCTRI/2023/07/055325Pt B.D. Sharma UHS Rohtak
已完成
Unknown
The efficacy of sacubitril/valsartan in patients with poorly controlled essential hypertension.HypertensionJPRN-UMIN000052604Tachibanadai clinic55
招募中
2 期
Investigating the effect of valsartan sacubitril on left ventricular functioIRCT20240117060713N1Ahvaz University of Medical Sciences92
已完成
Unknown
Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with HypertensioEnd-stage renal failureJPRN-UMIN000049348Kansai Medical University27